Services

Functional genomics solutions powered by geneSlice — from target validation to clinical trial design.

Every service we offer is built on geneSlice®, our proprietary gene editing platform. The platform is the same; what varies is the question, the gene, the variant space, and the readout. The services below describe the most common project shapes we work in. If your project doesn't fit cleanly into one of them, Custom Services is the right entry point.

ServiceWho it's forWhat you receive
OncologyPharma and biotech with cancer drug programmesVariant-level drug sensitivity data for patient stratification, label expansion, and resistance anticipation.Learn more
Rare Genetic DiseasesPharma, biotech, and academic groups working in rare disease, neurodegenerative, cardiovascular, and other genetically defined disordersCell models and functional assays confirming pathogenicity and predicting therapeutic response.Learn more
Compound–Target AssayMed-chem teams developing small-molecule drugsResidue-level resistance and sensitivity mapping for compound–target interactions.Learn more
Custom ServicesProgrammes outside the standard project shapesBespoke assay design — arrayed per-variant studies, tagging-based engagement assays, custom phenotypic endpoints.Learn more
CRISPR TherapeuticsDevelopers of CRISPR-based therapiesCharacterisation of bystander mutations, off-target effects, and unintended edits introduced by therapeutic editors.Learn more
Routing aid

Which service is right for you?

  • Working on a cancer drug programme? Start with Oncology.
  • Working on a programme in rare genetic disease, neurodegenerative disease, cardiovascular disease, or another genetically defined disorder? Start with Rare Genetic Diseases.
  • Developing a small molecule and need residue-level interaction data? See Compound–Target Assay.
  • Developing a CRISPR-based therapy and need to characterise editing outcomes? See CRISPR Therapeutics.
  • Don't fit the above, or have a question that needs a custom assay? See Custom Services or book a meeting.

Talk to our team.

Tell us your gene target, disease area, project stage, and preferred timeline.

Book a meetingContact us